Gautam Banik

Dr. Gautam Banik is the Chief Technology Officer at Neurona Therapeutics. Previously, Gautam was the Vice President of Manufacturing and Process Sciences at Neurona Therapeutics. Prior to joining Neurona he was Vice President of Manufacturing and Process Sciences at Cellerant Therapeutics where he developed a myeloid progenitor stem cell product derived from adult donors for the treatment of neutropenia in acute myelogenous leukemia and acute radiation syndrome. Gautam also developed an antibody drug conjugate product for the treatment of AML for early phase clinical studies. Prior to Cellerant, he worked in the Process Sciences group at Cell Genesys from 1997 to 2008. During this period, he held a number of positions with increasing responsibility including leading the development of manufacturing processes and scale up to commercial scale for cell therapy products such as GVAX immunotherapy. He also worked on a number of gene therapy and viral vector products. He conducted his post-doctoral research in Biochemical Engineering at the University of Colorado at Boulder and received his Ph.D. in Engineering Sciences from Dartmouth College.